Fasenra shows benefit in acute asthma and COPD in Phase II trial

Fasenra shows benefit in acute asthma and COPD in Phase II trial

Source: 
Clinical Trials Arena
snippet: 

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and COPD.